Related Experiment Video

Updated: Oct 13, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles

C E Hughes, W H Beggs

    The Journal of Antimicrobial Chemotherapy
    |February 1, 1987
    PubMed

    Insights

    Fluconazole demonstrated fungistatic activity against Candida species, similar to other oral azoles like ketoconazole. This antifungal agent showed no significant advantage over existing treatments in early studies.

    Area of Science:

    • Mycology
    • Pharmacology
    • Antimicrobial Agents

    Background:

    • Candida species are common causes of fungal infections.
    • Azole antifungals are widely used for treating candidiasis.
    • Evaluating new antifungal agents is crucial for combating drug resistance.

    Purpose of the Study:

    • To assess the in vitro fungistatic activity of fluconazole.
    • To compare fluconazole's efficacy against Candida species with other oral azoles.

    Main Methods:

    • Viability studies were conducted on three strains of Candida species.
    • Antifungal activity was tested against yeasts in stationary and early logarithmic phases.
    • Fluconazole was compared to ketoconazole, vibunazole, and ICI 153,066.

    Main Results:

    • Fluconazole exhibited strictly fungistatic activity against all tested Candida strains.
    • No significant difference in activity was observed between fluconazole and the other oral azole agents.
    • The phase of yeast growth (stationary or early logarithmic) did not alter fluconazole's activity.

    Conclusions:

    • Fluconazole's in vitro activity against Candida species is fungistatic.
    • Fluconazole does not offer a therapeutic advantage over existing oral azole antifungals based on these findings.
    • Further research may be needed to explore fluconazole's clinical utility and potential advantages in specific contexts.

    More Related Videos

    Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance08:45

    Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

    Published on: December 28, 2017

    Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells09:27

    Automation of Bio-Atomic Force Microscope Measurements on Hundreds of C. albicans Cells

    Published on: April 2, 2021

    Related Concept Videos

    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Candidiasis01:20

    Candidiasis

    Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
    Inhibitors of Bacterial DNA Synthesis01:28

    Inhibitors of Bacterial DNA Synthesis

    Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
    Antiviral Nucleoside Inhibitors01:22

    Antiviral Nucleoside Inhibitors

    Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
    Antifungal Agents01:15

    Antifungal Agents

    Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...